Thyroid Ultrasound Follow-Up for TR3 and TR4 Nodules

Initial Management Strategy

• For TR3 nodules, perform ultrasound follow-up at 12, 24, and 60 months; for TR4 nodules, perform ultrasound follow-up at 12, 24, and 60 months, with consideration for FNA biopsy at initial evaluation if the nodule meets size criteria (≥1.5 cm for TR4, ≥2.5 cm for TR3) 1

Surveillance Ultrasound Schedule

• Perform ultrasound at 12 months after initial evaluation for both TR3 and TR4 nodules to establish nodule stability and detect early changes in characteristics 1
• Perform ultrasound at 24 months and 60 months after initial evaluation 1

What to Assess at Each Follow-Up Visit

• Measure nodule dimensions in three planes and calculate volume reduction rate using: [(Initial volume – Current volume) × 100]/Initial volume 1
• Assess for new suspicious features: microcalcifications, irregular margins, marked hypoechogenicity, taller-than-wide shape, or abnormal vascularity 1, 2, 3, 4
• Evaluate nodule composition changes: solid versus cystic components, echogenicity alterations 1, 4
• Screen for new nodules in the thyroid gland 1

Triggers for Additional Evaluation

• Nodule growth ≥3 mm in any dimension warrants repeat FNA biopsy 1
• Development of microcalcifications, irregular borders, marked hypoechogenicity, or taller-than-wide morphology requires repeat FNA regardless of prior benign cytology 1, 2, 3, 4

Critical Pitfalls to Avoid

• Do not assume TR3 and TR4 nodules below size thresholds are benign: 10% of TR3 nodules <2.5 cm and 38% of TR4 nodules <1.5 cm are malignant 1
• The majority of TR4 (78.9%) and TR5 (64.6%) nodules have benign cytology, but this does not eliminate the need for surveillance 2, 3, 5

Special Considerations for Multiple Nodules

• When multiple nodules are present, the nodule with the highest TI-RADS score should guide management 4
• If nodules have similar TI-RADS scores, the largest nodule should be prioritized for FNA and surveillance 4

Evidence Quality and Limitations

• The surveillance intervals recommended are based primarily on expert consensus and observational data rather than randomized controlled trials 1